8.48
0.17 (2.05%)
| Penutupan Terdahulu | 8.31 |
| Buka | 8.18 |
| Jumlah Dagangan | 168,921 |
| Purata Dagangan (3B) | 189,843 |
| Modal Pasaran | 201,980,016 |
| Harga / Jualan (P/S) | 0.650 |
| Harga / Buku (P/B) | 1.18 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Feb 2025 - 3 Mar 2025 |
| Margin Keuntungan | -15.89% |
| Margin Operasi (TTM) | -7.90% |
| EPS Cair (TTM) | -2.25 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.87% |
| Nisbah Semasa (MRQ) | 2.66 |
| Aliran Tunai Operasi (OCF TTM) | 5.78 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.52 M |
| Pulangan Atas Aset (ROA TTM) | -9.66% |
| Pulangan Atas Ekuiti (ROE TTM) | -25.33% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Inogen, Inc | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | -2.0 |
| Purata | -1.83 |
|
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.80% |
| % Dimiliki oleh Institusi | 89.68% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 30 Dec 2024 | Pengumuman | Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device |
| 07 Nov 2024 | Pengumuman | Inogen Announces Third Quarter 2024 Financial Results |
| 04 Nov 2024 | Pengumuman | Inogen to Present at Upcoming Investor Conferences |
| 17 Oct 2024 | Pengumuman | Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024 |
| 08 Oct 2024 | Pengumuman | Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |